Shaping the future of translational science
The IBRI is entering an exciting era driven by significant advancements in our abilities to study complex disease processes and propose new ways to intervene toward improving patients’ lives.
Much of this has been inspired by what we can now study and learn directly from patients in the form of novel genetic and genomic analyses of disease tissues along with human-derived models for preclinical experimental work.
These approaches have led to a better molecular understanding of disease and patient heterogeneity, in addition to new therapeutic hypotheses to explore. It is ultimately our goal to return these findings to patients in the form of novel therapies and diagnostics that improve disease outcomes.
We therefore envision translational science as a cyclical process of continual learning and applied research that begins and ends with the patient. Through the lens of a research institute, there are multiple entry points from diverse scientific disciplines for insights, hypothesis generation and medical innovation leading to potential breakthroughs.
The four foundational areas of scientific focus at the IBRI will provide us the core talent and capability to pursue translational science in this new patient-centric framework.
IBRI Integrated Matrix
